Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.23822/EurAnnACI.1764-1489.345 | DOI Listing |
J Pharm Pract
February 2025
Michigan Medicine, Ann Arbor, MI, USA.
Eur Ann Allergy Clin Immunol
May 2024
Department of Allergy, Faculty of Medicine, Complejo Hospitalario Universitario de Santiago, University of Santiago de Compostela, Santiago de Compostela, Spain.
J Evid Based Med
June 2024
Department of Pediatrics, Universidad de Antioquia, Medellín, Colombia.
Aim: To determine the comparative effectiveness of fluid schemes for children with diabetic ketoacidosis (DKA).
Methods: We conducted a systematic review with an attempt to conduct network meta-analysis (NMA). We searched MEDLINE, EMBASE, CENTRAL, Epistemonikos, Virtual Health Library, and gray literature from inception to July 31, 2022.
CJEM
March 2024
Ontario Poison Centre, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, ON, Canada.
Background: Acetaminophen overdose is a leading cause of acute liver failure in developing countries. N-acetylcysteine (NAC) is a highly effective antidote for acetaminophen hepatotoxicity, typically initiated in the emergency department. Due to a known high rate of errors with the standard three-bag IV NAC protocol, in 2019, the Ontario Poison Center changed to a modified 3% IV NAC one-bag protocol.
View Article and Find Full Text PDFCurr Opin Clin Nutr Metab Care
March 2024
Critical Care Division, The George Institute for Global Health, Sydney, New South Wales.
Purpose Of Review: To evaluate recent evidence (2021-2023) on fluid therapy in diabetic ketoacidosis. Key evidence gaps which require generation of new evidence are discussed.
Recent Findings: Balanced crystalloid solutions, compared to the commonly recommended and used 0.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!